The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1390
May 14, 2012
View Complete Issue         Table of Contents 2019 
Off-Label Use of Ketorolac for Athletic Injuries
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Off-Label Use of Ketorolac for Athletic Injuries
May 14, 2012 (Issue: 1390)
Recent reports indicate that intramuscular (IM) injection of the nonsteroidal anti-inflammatory drug (NSAID) ketorolac (Toradol, and others), sometimes directly into injured muscles, has become a common practice in US locker rooms.
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App for iOS, Android, and Kindle Fire
  • FREE online per issue CME/CE
Purchase this article:
Title: Off-Label Use of Ketorolac for Athletic Injuries
Article code: 1390a
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.